Jonathan David Eisenberg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Radiation-Induced | 9 | 2015 | 540 | 1.030 |
Why?
|
| Radiation Dosage | 7 | 2015 | 1944 | 0.950 |
Why?
|
| Life Expectancy | 5 | 2015 | 1247 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2017 | 20659 | 0.500 |
Why?
|
| Decision Making | 5 | 2015 | 3965 | 0.450 |
Why?
|
| Radiography, Abdominal | 1 | 2017 | 544 | 0.430 |
Why?
|
| Abdominal Pain | 2 | 2017 | 1069 | 0.430 |
Why?
|
| Medical History Taking | 1 | 2012 | 777 | 0.300 |
Why?
|
| Benchmarking | 1 | 2014 | 1052 | 0.280 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 993 | 0.280 |
Why?
|
| Radiometry | 1 | 2012 | 804 | 0.270 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1181 | 0.260 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1458 | 0.220 |
Why?
|
| Radiography | 2 | 2014 | 6919 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2017 | 4863 | 0.190 |
Why?
|
| Catheter Ablation | 1 | 2015 | 2788 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 3181 | 0.160 |
Why?
|
| Renal Artery Obstruction | 2 | 2009 | 218 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4274 | 0.150 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 608 | 0.120 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 3529 | 0.120 |
Why?
|
| Risk Assessment | 8 | 2015 | 24282 | 0.120 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2014 | 5 | 0.110 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2014 | 183 | 0.110 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 249 | 0.100 |
Why?
|
| Hypertension, Renovascular | 2 | 2009 | 113 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2017 | 2263 | 0.090 |
Why?
|
| Age Distribution | 1 | 2017 | 2858 | 0.090 |
Why?
|
| Risk Management | 1 | 2014 | 559 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2015 | 5089 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 622 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14652 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2015 | 10070 | 0.070 |
Why?
|
| Appendicitis | 1 | 2014 | 679 | 0.070 |
Why?
|
| Stents | 2 | 2009 | 3213 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2015 | 1383 | 0.070 |
Why?
|
| Pneumonia | 1 | 2019 | 2157 | 0.070 |
Why?
|
| Models, Economic | 1 | 2011 | 716 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2012 | 786 | 0.070 |
Why?
|
| Drug-Eluting Stents | 2 | 2009 | 683 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2015 | 2590 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2011 | 697 | 0.060 |
Why?
|
| Linear Models | 2 | 2013 | 5876 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 1315 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3286 | 0.060 |
Why?
|
| Coronary Vessels | 2 | 2009 | 3096 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1182 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 851 | 0.050 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11499 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 15842 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1727 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1545 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2003 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 5526 | 0.050 |
Why?
|
| Male | 16 | 2019 | 363698 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3278 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20124 | 0.050 |
Why?
|
| Middle Aged | 12 | 2017 | 223009 | 0.050 |
Why?
|
| Aged | 11 | 2016 | 171117 | 0.050 |
Why?
|
| Female | 16 | 2019 | 396112 | 0.050 |
Why?
|
| Communication | 1 | 2015 | 3916 | 0.050 |
Why?
|
| Mammography | 1 | 2012 | 2423 | 0.050 |
Why?
|
| Humans | 22 | 2019 | 765968 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3454 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 59489 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 7875 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2009 | 208 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36532 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 8297 | 0.030 |
Why?
|
| Coronary Thrombosis | 1 | 1999 | 440 | 0.030 |
Why?
|
| Comorbidity | 3 | 2015 | 10563 | 0.030 |
Why?
|
| Incidence | 4 | 2015 | 21480 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1999 | 956 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11840 | 0.030 |
Why?
|
| Risk Factors | 3 | 2017 | 74840 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 59889 | 0.030 |
Why?
|
| United States | 3 | 2017 | 72903 | 0.030 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 293 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1993 | 228 | 0.030 |
Why?
|
| Adult | 8 | 2016 | 223044 | 0.030 |
Why?
|
| Risk | 2 | 2014 | 9591 | 0.020 |
Why?
|
| Markov Chains | 1 | 2015 | 968 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2015 | 6255 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9338 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12509 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6544 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12795 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 955 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2013 | 424 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 11206 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Informed Consent | 1 | 2015 | 1010 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2009 | 238 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 13451 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1221 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 1999 | 4493 | 0.020 |
Why?
|
| Recurrence | 2 | 2009 | 8501 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 1238 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3475 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2016 | 54802 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 553 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 22340 | 0.010 |
Why?
|
| Metals | 1 | 2009 | 710 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2887 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21056 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6832 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1993 | 1287 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 8067 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3615 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8733 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 2780 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2105 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 1531 | 0.010 |
Why?
|
| Time Factors | 3 | 2009 | 40065 | 0.010 |
Why?
|
| Angioscopy | 1 | 1999 | 46 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 4184 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13266 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 3236 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 1946 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18380 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7066 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 9373 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 8532 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 65188 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 14071 | 0.010 |
Why?
|
| Aerosols | 1 | 1993 | 633 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2009 | 81514 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3432 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6203 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12976 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 15398 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1993 | 12437 | 0.000 |
Why?
|
| Lung | 1 | 1993 | 10033 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1993 | 39193 | 0.000 |
Why?
|
| Quality of Life | 1 | 1993 | 13462 | 0.000 |
Why?
|
| Adolescent | 1 | 1993 | 88835 | 0.000 |
Why?
|